Disclosures for "Evaluation of Olfactory Function Through Smell Testing and Nasal Brushing in Patients With COVID-associated Chemosensory Dysfunction and Recovery"
-
Dr. Ergun has nothing to disclose.
-
Dr. Albers has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for AROMHA, Inc. An immediate family member of Dr. Albers has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Aromha, Inc. An immediate family member of Dr. Albers has stock in Berkshire Hathaway. An immediate family member of Dr. Albers has stock in Curis. The institution of an immediate family member of Dr. Albers has received research support from NIH. An immediate family member of Dr. Albers has received intellectual property interests from a discovery or technology relating to health care.
-
Mr. Magdamo has received research support from NIH. Mr. Magdamo has received intellectual property interests from a discovery or technology relating to health care.
-
Mr. Zhang has nothing to disclose.
-
The institution of Dr. Shin has received research support from NIH RO1. The institution of Dr. Shin has received research support from NIH U Grant. The institution of Dr. Shin has received research support from UCB. The institution of Dr. Shin has received research support from Biogen. The institution of Dr. Shin has received research support from Neuropace. The institution of Dr. Shin has received research support from Praxis Precision Medicine.
-
Miss Minichetti has nothing to disclose.
-
Dr. Sinha has nothing to disclose.
-
Mr. Milstein has nothing to disclose.
-
Mr. Bhukar has nothing to disclose.
-
Ms. Agirman has nothing to disclose.
-
Dr. Avetisyan has nothing to disclose.
-
Dr. Holbrook has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Rhino Therapeutics. Dr. Holbrook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axiom Labs. The institution of Dr. Holbrook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lyra. Dr. Holbrook has stock in Rhino Therapeutics. Dr. Holbrook has stock in Axiom Labs. Dr. Holbrook has received publishing royalties from a publication relating to health care.
-
Dr. Bankova has nothing to disclose.
-
An immediate family member of Dr. Albers has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Aromha. Dr. Albers has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Aromha. Dr. Albers has stock in Berkshire Hathaway. Dr. Albers has stock in Curis. The institution of Dr. Albers has received research support from NIH. Dr. Albers has received intellectual property interests from a discovery or technology relating to health care.